Repligen Completes Acquisition of BioLife Solutions

manilatimes.net · 2026-10-06

WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, 'Repligen”, or the 'Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS, 'BioLife”), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market.

Read the full story at manilatimes.net →